|
|
Effect of Mirena in the treatment of complex endometrial hyperplasia |
ZHANG Ji LI Xue-nian HUANG Ping WANG Ling |
Department of Obstetrics and Gynecology,Ganzhou Municipal Hospital,Jiangxi Province,Ganzhou 341000,China |
|
|
Abstract ObjectiveTo explore the clinical effect of Mirena in the treatment of complex endometrial hyperplasia.MethodsFifty patients with complex endometrial hyperplasia treated in our hospital from January 2014 to March 2016 were evenly assigned to the two groups according to the parity of the admission order:observation group(even)and control group (odd).The control group was given routine treatment,the observation group was given the conventional treatment based on the use of Mirena treatment.The pathological changes of endometrium were observed by hysteroscopy before treatment,and after 3,6,9 months of treatment,and the clinical effect of treatment was evaluated.ResultsAfter 3,6,9 months of treatment,hemoglobin,menstrual score,and endometrial thickness was better than that before treatment,and over time,the indicators was better than the previous one(P<0.05).After 3,6,9 months of treatment,the indexes of the observation group were better than those of the control group,the differences were statistically significant(P<0.05).The total effective rate was 96.00%in the observation group,was higher than 68.00%in the control group,the difference was statistically significant(P<0.05).ConclusionThe effect of using Mirena is significant in the treatment of complex endometrial hyperplasia,and it has obvious effect in improving the hemoglobin value,menstrual score and endometrial thickness.It has clinical application and popularization value.
|
|
|
|
|
[10] |
马阿影,谢淑武,朱焰.子宫内膜增生症的药物治疗研究进展[J].中国新药杂志,2016,25(23):2683-2687.
|
[11] |
詹士华.100例子宫内膜增生过长患者采用左炔诺孕酮宫内缓释系统临床效果研究[J].当代医学,2015,21(15):86-87.
|
[12] |
张海艳,栾继红,李晓红.左炔诺孕酮宫内节育系统治疗子宫内膜单纯性增生过长的临床疗效观察[J].中国卫生标准管理,2015,6(13):143-144.
|
[13] |
张纯溪,岳慧敏.促性腺激素释放激素激动剂与左炔诺孕酮宫内节育器联合治疗子宫内膜不典型增生的临床疗效研究[J].中国计划生育和妇产科,2016,8(6):56-58.
|
[1] |
褚兆苹,李红艳,马国娟,等.左炔诺孕酮宫内缓释系统在围绝经期子宫内膜增生(不伴非典型性)患者中的应用[J].中国医药,2016,11(12):1832-1835.
|
[2] |
Froio E,Piana S,Cavazza A,etal.MultifocalPEComa (PEComatosis)of the female genital tract associated with endometriosis,diffuse adenomyosis,and endometrial atypical hyperplasia[J].Int J Surg Pathol,2014,16(4):443-446.
|
[3] |
李磊.左炔诺孕酮宫内缓释系统及孕激素治疗子宫内膜增生症的疗效比较[J].实用妇科内分泌杂志(电子版),2016,3(7):81-82.
|
[4] |
李磊.良性子宫内膜增生症采用左炔诺孕酮宫内缓释系统治疗的疗效观察[J].实用妇科内分泌杂志(电子版),2015,2(12):192-193.
|
[5] |
Higharn JM,O’Brien PM,Shaw RW.Assessment of menstrual blood loss using a pictorial chart[J].Br J Obstet Gy necol,1990,97(8):734-739.
|
[6] |
刘惠.左炔诺孕酮宫内缓释系统治疗子宫内膜增生症的临床及内膜超微结构研究[J].中外医疗,2015,34(7):139-140.
|
[7] |
邹宏兵,郑江红.左炔诺孕酮宫内缓释系统治疗功能失调性子宫出血及子宫内膜增生过长临床疗效研究[J].中国性科学,2015,24(1):19-21.
|
[8] |
林燕霞.曼月乐及左炔诺孕酮治疗子宫内膜增生症的临床效果比较[J].临床医学工程,2016,23(4):453-454.
|
[9] |
奚滕滕,崔秀娟,孙燕娜.左炔诺孕酮宫内缓释系统治疗子宫内膜单纯性增生过长的研究[J].国际妇产科学杂志,2014,41(6):680-682.
|
[14] |
黄禾.左炔诺孕酮宫内缓释系统在妇科疾病的临床应用[J].生殖医学杂志,2016,25(6):580-584.
|
[15] |
柴明涵.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,6(3):30-32.
|
|
|
|